Latest advances in mHSPC from ASCO GU 2020
Dr Eleni Efstathiou and Prof Axel Merseburger
14 Feb 2020
ASCO GU 2020: Updates in renal cancer
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
14 Feb 2020
Beyond p-values: When does clinical impact outweigh statistical significance?
Prof Matthew Sydes - University College London, London, UK
14 Feb 2020
Prostate-specific membrane antigen PET: Who should undergo advanced imaging?
Dr Jérémie Calais - David Geffen School of Medicine UCLA, Los Angeles, USA
14 Feb 2020
Latest in prostate: Updates from TITAN, CARD and the era of personalised medicin...
Prof Karim Fizazi, Dr Elena Castro and Prof Axel Merseburger
14 Feb 2020
Echo-guided biopsy versus digital-guided biopsy of the prostate
Dr Mbassi Achille Aurèlei - Yaounde Central Hospital, Yaounde, Cameroon
7 Feb 2020
The risk of prostate cancer amongst African and Caribbean men in the UK
Prof Frank Chinegwundoh - Barts Health NHS Trust, London, UK
7 Feb 2020
Surgical innovations in Sub-Saharan Africa
Prof Frank Chinegwundoh - Barts Health NHS Trust, London, UK
7 Feb 2020
Where have we got to with cancer treatment?
Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology, Utrech...
27 Jan 2020
Updated recommendations for the management of elderly prostate cancer patients
Dr Helen Boyle - Le Centre Léon Bérard, Lyon, France
4 Dec 2019
Managing prostate cancer in older patients: Updates in the SIOG guidelines
Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France
29 Nov 2019
Should breast and colorectal cancer screening be carried out in older adults?
Dr Shabbir Alibhai - Princess Margaret Cancer, Toronto, Canada
29 Nov 2019
